The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

  • Industry investment SC’s largest ever with 1,500 jobs

  • gold price: Gold likely to consolidate ahead of the US FOMC decision

  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

Stock Shares
Home›Stock Shares›Equinor ASA: Share buy-back

Equinor ASA: Share buy-back

By Megan
May 23, 2022
58
0
Share:

Please see below information about transactions made under the share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR).

Date on which the second tranche of the share buy-back programme for 2022 was announced: 4 May 2022.

The duration of the second tranche of the buy-back programme for 2022: 16 May to no later than 26 July 2022.

Size of the buy-back programme: Up to 75,000,000 shares, with a maximum total consideration for the second tranche: USD 440,000,000.

From 16 May until 20 May, Equinor ASA has purchased a total of 1,307,928 own shares at the Oslo Stock Exchange at an average price of NOK 336.1768 per share.

Aggregated overview of transactions per day:

Date Aggregated volume (number of shares) Weighted average share price (NOK) Total transaction value (NOK
       
16 May 333,000 330.7705 110,146,576.50
17 May      
18 May 321,928 341.4968 109,937,381.83
19 May 324,000 335.8604 108,818,769.60
20 May 329,000 336.7546 110,792,263.40
       
Previously disclosed buy-backs under the second tranche of the 2022 programme (accumulated)      
Previously disclosed buy-backs under the 2021 programme and first tranche of the 2022 programme (accumulated) 27,131,791 247.4239 6,713,054,517.08
Total buy-backs under the 2021 and 2022 programme 28,439,719 251.5056 7,152,749,508.41

Following the completion of the above transactions, Equinor ASA owns a total of 38,306,217 own shares, corresponding to 1.18% of Equinor ASA’s share capital, including shares under Equinor’s share savings programme.

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix:
A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Further information from

Investor relations
Peter Hutton, senior vice president Investor Relations,
+44 7881 918 792 (mobile)

Media
Sissel Rinde, vice president Media Relations,
+ 47 412 60 584 (mobile)

  • Detailed overview of transactions
  • Aggregated overview of transactions

Source link

TagsEquinor ASAOslo Stock Exchange:EQNR
Previous Article

Vino Vault Welcomes Investment – Los Angeles ...

Next Article

Investment Strategist Lyn Alden Calls Mid-$20,000 $BTC ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Investment

    These 6 low-debt global stocks are set to outperform, Bernstein says

    January 24, 2023
    By Megan
  • Stock Shares

    Buy-back of shares to share programmes for

    July 19, 2022
    By Megan
  • Stock Shares

    Cathie Wood’s ARK Invest adds more Bitcoin exposure as GBTC, Coinbase stock hit new lows

    November 22, 2022
    By Megan
  • Stock Shares

    Weber Shares Are Down. Why the Stock Got a Downgrade.

    August 1, 2022
    By Megan
  • Stock Shares

    Stock Commentary: Philex Mining shares to list after underwhelming SRO

    August 2, 2022
    By Megan
  • Stock Shares

    Multibagger stocks: 5 shares give up to 500% YTD return. Do you own any one?

    July 25, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Currencies

    Iranian currency rates for October 9

  • Investment

    J&J expands in Ireland with a $100M+ investment for contact lens manufacturing site – Endpoints News

  • Brokers

    Why rig-handling analytics are now key for brokers insuring trucking firms

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • January 29, 2023

    Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

  • January 29, 2023

    Industry investment SC’s largest ever with 1,500 jobs

  • January 29, 2023

    gold price: Gold likely to consolidate ahead of the US FOMC decision

  • January 29, 2023

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • January 29, 2023

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

Best Reviews

Latest News

Stock Shares

Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

Trust Financial Corp. Disclosed to the Securities and Exchange Commission in its most recent Form 13F filing that during the third quarter, it reduced its holdings in AXIS Capital Holdings ...
  • Industry investment SC’s largest ever with 1,500 jobs

    By Megan
    January 29, 2023
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Recent

  • Popular

  • Comments

  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    By Megan
    January 29, 2023
  • Industry investment SC’s largest ever with 1,500 jobs

    By Megan
    January 29, 2023
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    By Megan
    January 29, 2023
  • Australia’s economy: boom or bust?

    By Megan
    September 9, 2019
  • Australian economy suffers virus symptoms

    By Megan
    February 10, 2020
  • Australian economy likely already slowing in Q2 before Delta downturn

    By Megan
    August 30, 2021

Trending News

  • Stock Shares

    Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    Trust Financial Corp. Disclosed to the Securities and Exchange Commission in its most recent Form 13F filing that during the third quarter, it reduced its holdings in AXIS Capital Holdings ...
  • Investment

    Industry investment SC’s largest ever with 1,500 jobs

    AP and T&D Reports COLUMBIA – Redwood Materials, a producer of anode and cathode battery components for electric vehicles, announced in December plans to establish operations near Ridgeville in Berkeley ...
  • Gold and Precious Metals

    gold price: Gold likely to consolidate ahead of the US FOMC decision

    Spot gold closed with a gain of nearly 0.1% in the week ending January 27. With US Q4 advance GDP, durable goods orders, weekly jobless claims, pending home sales, and ...
  • Stock Shares

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    The most recent report that Raymond James & Associates submitted to the Securities and Exchange Commission indicates that the investment firm liquidated a portion of its holdings in Masonite International ...
  • Stock Shares

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    Raymond James & Associates disclosed in its most recent 13F filing with the Securities and Exchange Commission that it increased its holdings in N.G.M. Biopharmaceuticals, Inc. (NASDAQ: N.G.M.) during the ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.